IHE icon

iShares US Pharmaceuticals ETF

130 hedge funds and large institutions have $140M invested in iShares US Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$651K
Puts
$242K
Net Calls
Net Calls Change

Top Buyers

1 +$4.08M
2 +$3.73M
3 +$3.14M
4
Goldman Sachs
Goldman Sachs
New York
+$2.49M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.84M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.3M
2
$13.4M
3
$8.06M
4
$7.34M
5
$7.21M
6
$7.05M
7
$6.89M
8
$6.86M
9
$5.71M
10
$5.18M
11
$4.97M
12
$4.05M
13
$3.73M
14
$3.12M
15
$2.48M
16
$2.45M
17
$1.83M
18
$1.6M
19
$1.32M
20
$1.2M
21
$1.17M
22
$1.16M
23
$1.11M
24
$1.08M
25
$1.01M